{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:58:20Z","timestamp":1791809900731,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.euroneuro.2010.08.008","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T08:39:43Z","timestamp":1285231183000},"page":"855-865","source":"Crossref","is-referenced-by-count":69,"title":["Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia"],"prefix":"10.1016","volume":"20","author":[{"given":"Monica","family":"Rais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeltje E.M.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiepke","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo G.","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilleke E.","family":"Hulshoff Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2010.08.008_bb0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archpsyc.1992.01820080023004","article-title":"The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0006-3223(98)00266-2","article-title":"Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology","volume":"45","author":"Baare","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2009.04.005","article-title":"Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study)","volume":"113","author":"Baeza","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.11.029","article-title":"Cannabis use and brain structural alterations in first episode schizophrenia\u2014a region of interest, voxel based morphometric study","volume":"99","author":"Bangalore","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00406-002-0366-5","article-title":"Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes","volume":"252","author":"Bersani","year":"2002","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1017\/S0033291706008440","article-title":"Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999","volume":"36","author":"Boydell","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(01)00249-3","article-title":"Precipitation and determination of the onset and course of schizophrenia by substance abuse\u2014a retrospective and prospective study of 232 population-based first illness episodes","volume":"54","author":"Buhler","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s004060050064","article-title":"Cannabis and schizophrenia: results of a follow-up study","volume":"249","author":"Caspari","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1109\/ISBI.2004.1398567","article-title":"Diffusion smoothing on brain surface via finite element method","volume":"1","author":"Chung","year":"2004","journal-title":"Biomedical Imaging: Nano to Macro, 2004 EEE Int. Symp."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2004.01.005","article-title":"Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample","volume":"71","author":"Compton","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pscychresns.2003.08.004","article-title":"Cerebral ventricular change over the first 10 years after the onset of schizophrenia","volume":"130","author":"DeLisi","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.schres.2006.05.006","article-title":"Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction","volume":"86","author":"Dubertret","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0070","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neubiorev.2005.12.002","article-title":"Cannabinoids and prefrontal cortical function: insights from preclinical studies","volume":"30","author":"Egerton","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cercor\/bhj136","article-title":"Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis","volume":"17","author":"Eggan","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.schres.2006.03.013","article-title":"Reduced size of the pre-supplementary motor cortex and impaired motor sequence learning in first-episode schizophrenia","volume":"84","author":"Exner","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1176\/appi.ajp.2008.08010147","article-title":"Cannabis, inhibitory neurons, and the progressive course of schizophrenia","volume":"165","author":"Freedman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0090","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0100","article-title":"Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use","author":"Gonzalez-Pinto","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eurpsy.2004.09.013","article-title":"Cannabis use and outcome of recent onset psychosis","volume":"20","author":"Grech","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1469-7610.2006.01658.x","article-title":"Childhood onset schizophrenia: cortical brain abnormalities as young adults","volume":"47","author":"Greenstein","year":"2006","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.57.8.761","article-title":"Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia","volume":"57","author":"Gur","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1176\/appi.ajp.2007.07081223","article-title":"Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia","volume":"165","author":"Hashimoto","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0125","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1176\/appi.ajp.162.12.2233","article-title":"Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies","volume":"162","author":"Honea","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0130","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archpsyc.58.12.1118","article-title":"Focal gray matter density changes in schizophrenia","volume":"58","author":"Hulshoff Pol","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1176\/appi.ajp.159.2.244","article-title":"Volume changes in gray matter in patients with schizophrenia","volume":"159","author":"Hulshoff Pol","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"Iversen","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881103174007","article-title":"Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients","volume":"17","author":"Jockers-Scherubl","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2004.08.045","article-title":"Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse","volume":"371","author":"Jockers-Scherubl","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/nimg.2000.0652","article-title":"Measurement of cortical thickness using an automated 3-D algorithm: a validation study","volume":"13","author":"Kabani","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroimage.2005.03.036","article-title":"Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification","volume":"27","author":"Kim","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/mol.105.016428","article-title":"Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity","volume":"69","author":"Kim","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","article-title":"Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis","volume":"194","author":"Koethe","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0959-4388(00)00068-4","article-title":"Schizophrenia and cognitive function","volume":"10","author":"Kuperberg","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0185","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archpsyc.60.9.878","article-title":"Regionally localized thinning of the cerebral cortex in schizophrenia","volume":"60","author":"Kuperberg","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0190","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0210","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.neuroimage.2006.10.041","article-title":"An unbiased iterative group registration template for cortical surface analysis","volume":"34","author":"Lyttelton","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0215","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/nimg.1999.0534","article-title":"Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI","volume":"12","author":"MacDonald","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0225","first-page":"1","article-title":"Neuroimaging in cannabis use: a systematic review of the literature","author":"Martin-Santos","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-0179-2-4","article-title":"Substance abuse in first-episode schizophrenic patients: a retrospective study","volume":"2","author":"Mauri","year":"2006","journal-title":"Clin. Pract. Epidemol. Ment. Health"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0235","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/cercor\/bhh172","article-title":"Mapping cortical thickness and gray matter concentration in first episode schizophrenia","volume":"15","author":"Narr","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biopsych.2005.03.043","article-title":"Cortical thinning in cingulate and occipital cortices in first episode schizophrenia","volume":"58","author":"Narr","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0245","first-page":"1","article-title":"Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings","author":"Navari","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2007.09.015","article-title":"Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication","volume":"98","author":"Nesvag","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0255","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/schbul\/sbi034","article-title":"Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia","volume":"31","author":"Pantelis","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0447.1992.tb01456.x","article-title":"Influence of cannabis abuse on schizophrenic psychopathology","volume":"85","author":"Peralta","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(02)03055-X","article-title":"Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study","volume":"948","author":"Pistis","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/appi.neuropsych.18.3.318","article-title":"Brain neuroimaging in cannabis use: a review","volume":"18","author":"Quickfall","year":"2006","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0275","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.2007.07071110","article-title":"Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients","volume":"165","author":"Rais","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0280","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures","volume":"45","author":"Robins","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0285","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/nimg.2000.0669","article-title":"Automated separation of gray and white matter from MR images of the human brain","volume":"13","author":"Schnack","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0295","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/brain\/awh554","article-title":"Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis","volume":"128","author":"Suzuki","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(99)00155-3","article-title":"Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia","volume":"43","author":"Szeszko","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0305","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1192\/bjp.bp.106.024521","article-title":"Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia","volume":"190","author":"Szeszko","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0310","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.schres.2006.12.033","article-title":"Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia","volume":"92","author":"Tregellas","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0315","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/appi.ajp.2008.08030411","article-title":"Increased hippocampal, thalamic, and prefrontal hemodynamic response to an urban noise stimulus in schizophrenia","volume":"166","author":"Tregellas","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(03)00018-5","article-title":"Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study","volume":"64","author":"van Haren","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0325","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.npp.1301347","article-title":"Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study","volume":"32","author":"van Haren","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0330","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2007.01.004","article-title":"Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood","volume":"63","author":"van Haren","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","article-title":"Cannabis use and age at onset of schizophrenia","volume":"161","author":"Veen","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0340","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(03)00065-9","article-title":"Gyrification abnormalities in childhood- and adolescent-onset schizophrenia","volume":"54","author":"White","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0345","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0925-4927(01)00109-3","article-title":"Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study","volume":"108","author":"Wible","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0350","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1176\/ajp.157.1.16","article-title":"Meta-analysis of regional brain volumes in schizophrenia","volume":"157","author":"Wright","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0355","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpsyc.65.6.694","article-title":"Regional brain abnormalities associated with long-term heavy cannabis use","volume":"65","author":"Yucel","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0360","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.08.008_bb0365","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1109\/TMI.2002.806283","article-title":"Automatic \u201cpipeline\u201d analysis of 3-D MRI data for clinical trials: application to multiple sclerosis","volume":"21","author":"Zijdenbos","year":"2002","journal-title":"IEEE Trans. Med. Imaging"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T02:18:29Z","timestamp":1591928309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X10001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0924977X10001860"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2010.08.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}